Skip to main content

These D.C.-area biotech companies are making progress on COVID-19. Here’s the latest.

From testing to treatments for the disease, a handful of Greater Washington players are doubling down during the pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.